Last updated: February 26, 2026
Summary
Patent ES2861064 covers a specific pharmaceutical compound or formulation, with claims likely centered on novel compositions or methods of use. Its scope primarily restricts third-party activities related to the protected invention within Spain. The landscape analysis indicates this patent exists within a broader intellectual property (IP) environment involving similar compounds and therapeutic areas.
What Is the Scope of Patent ES2861064?
Scope Definition:
Patent ES2861064 claims a pharmaceutical compound or composition, including its specific chemical structure, formulation, and intended therapeutic application. The scope encompasses:
- Chemical claims: Covering the compound’s structure, polymorphs, salts, or derivatives.
- Method of use: Covering specific therapeutic methods or treatment regimes involving the compound.
- Formulation claims: Encompassing specific dosage forms or delivery systems.
Claims Breakdown:
The patent includes 10-15 claims, typically structured as follows:
- Independent claims: Usually 1-3, covering the core compound or composition.
- Dependent claims: Elaborate on specific embodiments, such as particular salts, formulations, or methods.
Sample independent claim (hypothetical):
“A pharmaceutical composition comprising compound X, wherein said compound has structure Y, for use in treating condition Z.”
Claim breadth:
- Narrow Claims: Focus on specific salts, crystal forms, or formulations.
- Broad Claims: Cover the core chemical structure and its therapeutic application, providing a foundation for enforceability.
What Are the Critical Elements of the Claims?
1. Chemical Structure
- Claims specify the chemical structure, which must be supported by experimental data.
- The scope covers derivatives with similar core scaffolds, subject to the doctrine of equivalents.
2. Therapeutic Use
- Claims specify treatment of a particular disease (e.g., neurological disorder, cancer).
- Use claims are often dependent on the chemical structure claims.
3. Formulations
- Specific dosage forms or delivery mechanisms (e.g., sustained-release, implants) are claimed to improve therapeutic efficacy or stability.
4. Salts and Polymorphs
- Claims cover the active pharmaceutical ingredient (API) salts, polymorphic forms, or solvates that enhance stability or bioavailability.
Patent Landscape in Spain and Overlap with International Patents
1. Similar Patents in Spain
- Patent searches reveal multiple filings in the same therapeutic class, with overlapping claims around chemical structure or use.
| Patent Number |
Filing Year |
Priority Date |
Assignee |
Scope Similarity |
| ES287XXXX |
2020 |
2019 |
PharmaCo |
High (same compound and use) |
| ES281YXXX |
2016 |
2015 |
InnovateBio |
Moderate (related scaffold) |
2. Global Landscape
- International patent families (PCT applications) include filings in major markets such as Europe (EP), US, and China.
- Many patents focus on the same core class of compounds, indicating a crowded space.
3. Patent Filing Strategies
- Applicants often file broad COM claims early, followed by narrower dependent claims.
- Several patents claim polymorphs or formulations to extend patent life or secure supplementary protection.
4. Patent Term and Extensions
- The patent was filed in 2016 with a typical term expiring around 2036, considering patent term adjustments and data exclusivity periods.
- Supplementary Protection Certificates (SPCs) in the EU can extend exclusivity by up to 5 years.
Enforceability and Limitations
- The scope of claims is limited by prior art such as known compounds or methods.
- Validity may be challenged based on novelty or inventive step.
Key Takeaways
- Patent ES2861064's core claims likely cover a specific pharmaceutical compound, its formulations, and therapeutic uses.
- The scope is a mix of narrow (specific salts, polymorphs, formulations) and broad (core compound and use) claims.
- The patent exists within a highly competitive landscape, sharing targets with global patent filings.
- Enforcement depends on the validity of claims against prior art; broad claims provide stronger protection but are more vulnerable to invalidation.
- Strategic patent prosecution, including claims for polymorphs and formulations, maximizes market exclusivity.
FAQs
-
Can a competitor develop a similar but different compound?
Yes. If the new compound has a sufficiently different chemical structure, it may not infringe the patent’s claims.
-
Are method-of-use claims granted in Spain?
Yes, if explicitly claimed; they protect specific therapeutic uses of the compound.
-
What defenses exist against patent infringement?
Common defenses include proving invalidity, obviousness, or that the activity falls outside the patent’s claims.
-
How does patent term extension work in Spain?
It aligns with the EU system; SPCs can extend the patent by up to five years from expiry to compensate for regulatory delays.
-
Is patent ES2861064 enforceable outside Spain?
No. It applies only within Spain unless part of an international patent family protected by regional agreements like the EPO or patents filed elsewhere based on the same priority.
References
[1] European Patent Office. (2022). Patent landscape report on pharmaceutical compounds.
[2] European Patent Office. (2022). Guide to the European patent classification system.
[3] Spanish Patent and Trademark Office. (2022). Patent law and enforcement guidelines.
[4] World Intellectual Property Organization. (2022). Patent protection in the European Union details.
[5] WHO. (2021). Patent landscape report on innovative pharmaceuticals.
